Yale Medicine

3 weeks ago | yalemedicine.org | Sonya Collins

If you often experience a stinging, burning, or scratchy feeling in your eyes, chances are you have chronic dry eye. It affects an estimated one in 10 U.S. adults—and research shows that this condition is on the rise. While experts believe that age and hormone changes are among the most common causes of chronic dry eye, our increasing reliance on smartphones, computers, and other screen-based technologies may explain the recent increase in cases.

1 month ago | yalemedicine.org | Carrie MacMillan |Carrie Macmillan

When Pramod Mistry, MD, a Yale Medicine expert in inherited liver diseases, cared for his first patient with Gaucher disease 35 years ago, he didn’t anticipate that his work with this rare genetic disorder might illuminate the understanding of more common conditions such as multiple myeloma and Parkinson’s disease. Dr. Mistry, director of the National Gaucher Disease Treatment Center at Yale, has focused his career on Gaucher, which affects one in 40,000 people worldwide.

1 month ago | yalemedicine.org | Cassie Shortsleeve

Nearly 15% of adults reported having trouble falling asleep most or every day in the past 30 days, according to a national survey. Meanwhile, research shows that more people are turning to a popular and readily available over-the-counter (OTC) sleep aid: melatonin supplements. That doesn’t surprise Brienne Miner, MD, MHS, a Yale Medicine geriatric and sleep medicine specialist.

1 month ago | yalemedicine.org | Carrie MacMillan |Carrie Macmillan

Clifford Bogue, MD, knew from a young age that he loved solving mysteries and working with children. As a boy, he devoured all the “Sherlock Holmes” books by Arthur Conan Doyle and spent many summers at a sleepaway camp in the mountains of North Carolina, where he worked as a camp counselor and program director.

1 month ago | yalemedicine.org | Carrie MacMillan |Carrie Macmillan

The Food and Drug Administration (FDA) recently approved a new, non-opioid prescription pill—suzetrigine. Sold under the brand name Journavx™, the drug is helpful in treating moderate-to-severe acute (short-term) pain in adults. Medical experts say suzetrigine, which is made by Vertex Pharmaceuticals, is not addictive because it works by blocking pain signals that originate in the peripheral nervous system, before they reach the brain.